2026 NPPES data Pulmonary Disease Physician NPI 1326073990 M.D.
Verify on CMS →

BARBARA GALKO, M.D.

Pulmonary Disease Physician in LAGUNA BEACH, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
168
Medicare Part D claims · 46 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
21%
generic claims · 79% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
83.9464/100
▲ 1 pts above national avg 83.1 · [object Object]
Industry payments
$656.6
12 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

BARBARA GALKO, M.D. reported a CMS MIPS final score of 83.9464/100 — above the 83.1 national average — and filed 168 Medicare Part D claims in 2023.

83.9464/100
MIPS score · +1 vs avg
168
Part D claims, 2023
21%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

BARBARA GALKO, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

84 42nd percentile higher than 42% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

BARBARA GALKO, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about BARBARA GALKO, M.D.?

Near national average

NPI registry status

Active

Issued 07/12/2006

NPI 1326073990

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

168 88% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

MIPS final score

83.9464/100 0.8464000000000027% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Pulmonary Disease Physician compares to other specialties among California providers

California providers

Pulmonary Disease Physician share within California

1. Pulmonary Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pulmonary Disease Physician share within California

Medicare quality performance — MIPS

BARBARA GALKO, M.D.'s 2023 MIPS final score plotted against the Pulmonary Disease Physician national average

Near national average
MIPS Final Score
83.9464/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pulmonary Disease Physician) — 83.9464/100 vs national avg 83.1

0%100%National avg83%83.9%
MIPS final score (Pulmonary Disease Physician) — 83.9464/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BARBARA GALKO, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 31852 S COAST HWY, LAGUNA BEACH, CA, 92651, with a listed phone of (949) 715-0505. NPI 1326073990 was issued on 07/12/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GALKO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 168 prescription claims written by this provider, covering 46 Medicare beneficiaries and totaling roughly $78K in drug spend, split 79% brand-name and 21% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 83.9464/100 for the 2023 performance year (Quality 95, Cost 46.3704), compared with the national average of 83.1.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

31852 S COAST HWY
LAGUNA BEACH, CA 92651

Provider Details

NPI 1326073990
Specialty Pulmonary Disease Physician
Credentials M.D.
Gender Female
NPI Issued 07/12/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

83.9464
Final Score
Avg: 83.1
95
Quality
46.3704
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where BARBARA GALKO, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

GEORGE K SHAHINIAN M D INCORPORATED
ALISO VIEJO, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BARBARA GALKO, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$657

Largest payer

GlaxoSmithKline, LLC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to BARBARA GALKO, M.D.. To verify BARBARA GALKO, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

BARBARA GALKO, M.D. — brand share 79.0%
Specialty average (est.)

79% brand-name claims vs 21% generic, on 168 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

168
Total Claims
$78K
Total Drug Cost
46
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
252
Total Day Supply
7,262
Brand vs Generic
79% brand / 21% generic
Brand Drug Cost
$77K
Generic Drug Cost
$894

Patient Demographics

Average Patient Age
78.0 years
Avg HCC Risk Score
1.28
Gender Split
74% female / 26% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What BARBARA GALKO, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Symbicort
Budesonide/Formoterol Fumarate
27
Breo Ellipta
Fluticasone/Vilanterol
19
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
18
Stiolto Respimat
Tiotropium Br/Olodaterol Hcl
14
Albuterol Sulfate Hfa
Albuterol Sulfate
12
Breztri Aerosphere
Budesonide/Glycopyr/Formoterol
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How BARBARA GALKO, M.D. fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

BARBARA GALKO, M.D.'s 168 claims are below the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as GALKO.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is BARBARA GALKO, M.D.'s specialty?
BARBARA GALKO, M.D. specializes in Pulmonary Disease Physician and practices in LAGUNA BEACH, California. Credentials: M.D..
How much does BARBARA GALKO, M.D. prescribe under Medicare Part D?
In 2023, BARBARA GALKO, M.D. wrote 168 Medicare Part D claims totaling $78K in drug costs for 46 beneficiaries.
What is BARBARA GALKO, M.D.'s Medicare quality score?
BARBARA GALKO, M.D. has a CMS MIPS Final Score of 83.9464/100 (Quality: 95, Cost: 46.3704). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is BARBARA GALKO, M.D. located?
BARBARA GALKO, M.D. is located at 31852 S COAST HWY, LAGUNA BEACH, CA, 92651. Phone: (949) 715-0505.
What is BARBARA GALKO, M.D.'s NPI number?
BARBARA GALKO, M.D.'s National Provider Identifier (NPI) is 1326073990, issued on 07/12/2006.
Does BARBARA GALKO, M.D. prescribe more brand-name or generic drugs?
BARBARA GALKO, M.D.'s prescribing is 79% brand-name and 21% generic drugs by claim count, with $77K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does BARBARA GALKO, M.D. prescribe most often?
Based on 2023 Medicare Part D data, BARBARA GALKO, M.D.'s most frequently prescribed drugs include Symbicort, Breo Ellipta, Trelegy Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BARBARA GALKO, M.D. accept Medicare?
BARBARA GALKO, M.D. appears in CMS Medicare data with 168 Part D claims and 46 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BARBARA GALKO, M.D.'s credentials?
BARBARA GALKO, M.D.'s NPI is 1326073990 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology